11 Oct The new drugs from Merck and AstraZeneca
Miguel Ángel Temprano, CEO of Orfeo Capital, intervenes in the program Closing Markets of the radio chain Intereconomia to analyze the two new drugs from Merck and AstraZeneca against Covid and the possible evolution of gas and oil prices.